NCT06481878View on ClinicalTrials.gov

Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins

RecruitingOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

October 11, 2024

Primary Completion Date

October 6, 2027

Study Completion Date

October 6, 2027

Conditions
Alzheimer Disease
Interventions
DIAGNOSTIC_TEST

faecal analysis

Collection of medical data and stool sampling

Trial Locations (1)

38043

RECRUITING

Grenoble Alpes University Hospital, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER